Form 4: Colgate-Palmolive COO Exercises, Sells Shares

Colgate-Palmolive's COO, Panagiotis Tsourapas, exercised stock options and subsequently sold a portion of the acquired common stock.

Summary

• Panagiotis Tsourapas, Chief Operating Officer of Colgate-Palmolive Co (CL), engaged in transactions involving company stock.
• On February 11, 2026, Tsourapas exercised options to acquire 35,000 shares of common stock at an exercise price of $76.41 per share.
• On the same day, Tsourapas sold 35,000 shares of common stock at a weighted average price of $94.6093 per share.
• On February 12, 2026, Tsourapas exercised options to acquire an additional 15,000 shares of common stock at an exercise price of $76.41 per share.
• Also on February 12, 2026, Tsourapas sold 15,000 shares of common stock at a weighted average price of $97.8074 per share.
• The sales were conducted with a portion of the proceeds delivered to the issuer for payment of the exercise price of options and related tax withholding.
• Following these transactions, Tsourapas directly holds 10,415 shares of common stock.
• Indirectly, Tsourapas holds 4,568 shares through the Issuer's 401(k) Plan Trustee and 60,745 shares through a Trust.
• The stock options became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While an insider sale can sometimes be seen negatively, this appears to be a routine exercise of options and sale for liquidity/tax purposes, indicating the executive is realizing value from prior compensation.

Positives

• The exercise of stock options indicates management's prior commitment to the company's long-term performance, as options are typically granted as incentive compensation.
• The sale price of the shares ($94.6093 and $97.8074) is significantly higher than the exercise price ($76.41), indicating a profitable transaction for the insider.

Negatives

• The sale of shares by a high-ranking executive (COO) could be interpreted by some investors as a signal, although it is often part of routine compensation and tax planning.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance; it reports past insider transactions.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving option exercises and subsequent sales, are common events in publicly traded companies. These transactions often reflect executive compensation structures and personal financial planning rather than a direct signal about the company's immediate operational outlook. The filing indicates a routine transaction for a senior executive.

Comparison to Industry Standards

• Insider sales following option exercises are a standard component of executive compensation and liquidity events across various industries, including consumer staples.
• Companies like Procter & Gamble (PG) and Unilever (UL), direct competitors to Colgate-Palmolive, frequently report similar Form 4 filings for their executives, reflecting the exercise of long-term incentive awards and subsequent share sales for tax and diversification purposes.
• The reported transactions align with typical practices for executives managing their equity compensation.

Related Party Transactions

• The transactions involve the exercise of stock options granted under the issuer's incentive compensation plan and subsequent sale of shares, which are standard dealings between an executive and the company as part of compensation.

Stakeholder Impact

• Shareholders: The sale of shares by a COO could be perceived differently by various shareholders; some might view it as a normal part of executive compensation, while others might interpret it as a lack of confidence, though the latter is less likely given the context of option exercise.
• Employees: No direct impact on employees is indicated.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions involving the exercise of stock options and subsequent sale of shares by a senior executive. Such transactions are common for executive compensation and tax planning and do not typically signal a fundamental change in the company's outlook or performance. Therefore, it does not provide a strong basis for a 'buy' or 'sell' recommendation, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

Colgate-Palmolive, CL, Insider Trading, Form 4, Stock Options, Executive Compensation, Panagiotis Tsourapas, Share Sale